“With the mobile device … users can register their ECG signal whenever arrhythmia or other heart symptoms occur,” Timo Varpula, principal scientist with VTT, the research center developing the device, said in a statement. “The device is also suitable for pre- and post-surgery monitoring of heart patients at home.”
Mr. Varpula also said the app enables remote patient monitoring and minimizes hospital visits by wirelessly transmitting data from smartphone to medical staff.
According to VTT, the device has been tested by about 30 users, including hospital patients and athletes, to detect atrial fibrillation, arrhythmia and a cardiac conduction disorder. Although the study is ongoing, researchers report patients using the device to monitor irregular heartbeat experience improved quality of life due to the quantifiable data the system gives them.
VTT estimates the device will go to market early next year.
More articles on health IT:
Are implantable chips the future of medical data storage?
Apple brings on YouTube-famous physician
Media groups sue FBI for not revealing how it unlocked iPhone
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
